# The Impact of Genotype on Pharmacokinetics and Antiplatelet Effects of Ticagrelor in Healthy Chinese

> **NCT03092076** · PHASE1 · COMPLETED · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 51 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT03092076
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-20
- **Primary completion:** 2015-10-24
- **Final completion:** 2016-06-16
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2017-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03092076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03092076, "The Impact of Genotype on Pharmacokinetics and Antiplatelet Effects of Ticagrelor in Healthy Chinese". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03092076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
